Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetuximab plus FOLFOX4 in previously treated metastatic colorectal cancer
NCT00061815Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Mar 2003
- Primary completion
- Dec 2004
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of KL-140 in colorectal cancer (CRC), sponsored by Eli Lilly and Company. Started Mar 2003; status: completed.
02
Drugs
KL-140
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00061815.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00061815.